Effect of blonanserin on cognitive and social function in acute phase Japanese schizophrenia compared with risperidone
Authors:
Open Access
- 1 March 2014
- journal article
- research article
- Published by Taylor & Francis in Neuropsychiatric Disease and Treatment
- Vol. 10, 527-533
Abstract
Background: This study aims to determine the effectiveness of blonanserin (BNS) on the cognitive and social functions of patients with schizophrenia compared with risperidone (RIS) during acute-phase (8-week) treatment. Methods: A total of 39 schizophrenia inpatients were included in this study. The subjects received either BNS (N=20) or RIS (N=19), and the clinical responses were evaluated periodically. The concomitant use of mood stabilizers was not allowed. Efficacy was assessed with the Positive and Negative Syndrome Scale for schizophrenia. Cognition was assessed using the Brief Assessment of Cognition in Schizophrenia, Japanese-language version. Social function was assessed using the Life Assessment Scale for the Mentally Ill. Results: For both groups, each assessment exhibited a decrease in the mean change from baseline on the Positive and Negative Syndrome Scale. The depression subscale was significantly improved in the BNS group compared with the RIS group at 8 weeks after administration. BNS improved verbal fluency and executive function (cognitive function) and daily living and work skills (social function). Compared with the RIS group, BNS was observed to improve daily living. Conclusion: BNS may improve psychotic symptoms, cognitive function, and daily living in patients with acute-phase schizophrenia. BNS may be superior to RIS in the improvement of daily living.Keywords
This publication has 27 references indexed in Scilit:
- The cognitive profile of aripiprazole differs from that of other atypical antipsychotics in schizophrenia patientsJournal of Psychiatric Research, 2012
- Schizophrenia patients are impaired in empathic accuracyPsychological Medicine, 2011
- Do patients with schizophrenia benefit from a self-referential memory bias?Schizophrenia Research, 2011
- Emotional intelligence in schizophreniaSchizophrenia Research, 2009
- Theory of mind deficits for processing counterfactual information in persons with chronic schizophreniaPsychological Medicine, 2008
- Effects of Olanzapine, Quetiapine, and Risperidone on Neurocognitive Function in Early Psychosis: A Randomized, Double-Blind 52-Week ComparisonAmerican Journal of Psychiatry, 2007
- The neurocognitive effects of aripiprazole: an open-label comparison with olanzapinePsychopharmacology, 2006
- A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophreniaInternational Journal of Neuropsychopharmacology, 2005
- Cognitive Factors in Schizophrenia: Causes, Impact, and TreatmentCNS Spectrums, 2004
- Improvement in cognitive function following a switch to ziprasidone from conventional antipsychotics, olanzapine, or risperidone in outpatients with schizophreniaSchizophrenia Research, 2004